AEGON ASSET MANAGEMENT UK Plc Has $8.11 Million Stock Position in Avantor, Inc. (NYSE:AVTR)

AEGON ASSET MANAGEMENT UK Plc cut its position in Avantor, Inc. (NYSE:AVTR) by 31.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 384,485 shares of the company’s stock after selling 179,488 shares during the period. AEGON ASSET MANAGEMENT UK Plc owned 0.06% of Avantor worth $8,105,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. State Street Corp grew its position in Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after acquiring an additional 8,206,695 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Avantor by 653.0% during the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock worth $159,740,000 after purchasing an additional 5,354,678 shares during the last quarter. FMR LLC increased its stake in shares of Avantor by 557.2% in the third quarter. FMR LLC now owns 4,675,283 shares of the company’s stock valued at $120,950,000 after buying an additional 3,963,912 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of Avantor by 18.2% in the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock valued at $457,710,000 after buying an additional 2,719,615 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in Avantor by 146.5% during the 3rd quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock worth $67,996,000 after buying an additional 1,562,018 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Stock Performance

Shares of AVTR stock opened at $22.07 on Friday. The stock has a market cap of $15.02 billion, a PE ratio of 47.97, a price-to-earnings-growth ratio of 3.53 and a beta of 1.28. The stock has a 50-day moving average of $21.50 and a 200-day moving average of $23.39. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. Avantor, Inc. has a one year low of $19.59 and a one year high of $28.00.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Raymond James lowered their price objective on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a research report on Tuesday, January 21st. Barclays lowered their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Robert W. Baird lowered their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, UBS Group reaffirmed a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $27.38.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.